GlaxoSmithKline (GSK) SWOT Analysis

WikiWealth | Stock, ETF, Mutual Fund Research | SWOT, 5 Forces Analysis » Stock Research | Free Equity Research and Analysis » Health Care Industry Research & Analysis » GSK-GlaxoSmithKline Stock Research, Ratings, and Analysis » GlaxoSmithKline (GSK) SWOT Analysis

Home > SWOT Analysis > GlaxoSmithKline (GSK) SWOT Analysis

Create a SWOT Analysis Update this SWOT

Create a SWOT Analysis Update this SWOT

Strengths


GSK
gjgjk
deep pockets
Promising Drug Pipeline
Diverse Business

Weaknesses


Mediocre management
reliance on break through drugs
Patent losses

Opportunities


Demographic Trends

Threats


Regulated Business

GlaxoSmithKline (GSK) SWOT Analysis Profile

GlaxoSmithKline plc. engages in the development, manufacture, and marketing of pharmaceuticals, vaccines, oral care, and other health-related products worldwide, as well as producing a line of energy, juice, chocolate malt drinks. GlaxoSmithKline brand names include Advair, Wellbutrin, Zofran, Valtrex, Paxil, Aquafresh, and Sensodyne. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email

Free Email Newsletter

Popular SWOT Analyses

Drop SWOT Analysis Ambatukam
Sandbox
Waste Management (WM) SWOT Analysis
Wachovia (WB) SWOT Analysis
hi/fn (HIFN) SWOT Analysis
China Life Insurance (LFC) SWOT Analysis
Toyota (TM) SWOT Analysis
Coca Cola (KO) SWOT Analysis